Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis

Angela Ceribelli, Natasa Isailovic, Maria de Santis, Elena Generali, Micaela Fredi, Ilaria Cavazzana, Franco Franceschini, Luca Cantarini, Minoru Satoh, Carlo Selmi

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

This study aims to characterize myositis-specific antibodies in a well-defined cohort of patients with idiopathic inflammatory myopathy and to determine their association with cancer. Sera from 40 patients with polymyositis, dermatomyositis, and controls were tested by protein and RNA immunoprecipitation to detect autoantibodies, and immunoprecipitation-Western blot was used for anti-MJ/NXP-2, anti-MDA5, and anti-TIF1γ/α identification. Medical records were re-evaluated with specific focus on cancer. Anti-MJ/NXP-2 and anti-TIF1γ/α were the most common antibodies in dermatomyositis. In six dermatomyositis cases, we found five solid forms of cancer and one Hodgkin’s lymphoma in long-term remission. Among patients with cancer-associated dermatomyositis, three were positive for anti-TIF1γ/α, two for anti-Mi-2, and one for anti-MJ/NXP-2. The strongest positivity of anti-TIF1γ was seen in two active forms of cancer, and this antibody was either negative or positive at low titers in the absence of cancer or in the 7-year remission Hodgkin’s lymphoma. Four out of twenty (20 %) patients with polymyositis had solid cancer, but no specific association with autoantibodies was identified; further, none of the four cases of antisynthetase syndrome had a history of cancer. No serum myositis-associated autoantibody was observed in control sera, resulting in positive predictive value 75 %, negative predictive value 78.5 %, sensitivity 50 %, specificity 92 %, and area under the ROC curve 0.7083 for the risk of paraneoplastic DM in anti-TIF1γ/α (+) patients. Myositis-specific autoantibodies can be identified thanks to the use of immunoprecipitation, and their association with cancer is particularly clear for anti-TIF1γ/α in dermatomyositis. This association should be evaluated in a prospective study by immunoprecipitation in clinical practice.

Original languageEnglish (US)
Pages (from-to)1-7
Number of pages7
JournalClinical Rheumatology
DOIs
StateAccepted/In press - Oct 20 2016
Externally publishedYes

Fingerprint

Myositis
Dermatomyositis
Autoantibodies
Immunoprecipitation
Neoplasms
Hodgkin Disease
Antibodies
Serum
Polymyositis
ROC Curve
Area Under Curve
Medical Records
transcriptional intermediary factor 1
Western Blotting
Prospective Studies
RNA
Sensitivity and Specificity

Keywords

  • Biomarkers
  • Cancer
  • Idiopathic inflammatory myositis
  • Immunoprecipitation

ASJC Scopus subject areas

  • Rheumatology

Cite this

Ceribelli, A., Isailovic, N., de Santis, M., Generali, E., Fredi, M., Cavazzana, I., ... Selmi, C. (Accepted/In press). Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis. Clinical Rheumatology, 1-7. https://doi.org/10.1007/s10067-016-3453-0

Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis. / Ceribelli, Angela; Isailovic, Natasa; de Santis, Maria; Generali, Elena; Fredi, Micaela; Cavazzana, Ilaria; Franceschini, Franco; Cantarini, Luca; Satoh, Minoru; Selmi, Carlo.

In: Clinical Rheumatology, 20.10.2016, p. 1-7.

Research output: Contribution to journalArticle

Ceribelli, A, Isailovic, N, de Santis, M, Generali, E, Fredi, M, Cavazzana, I, Franceschini, F, Cantarini, L, Satoh, M & Selmi, C 2016, 'Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis', Clinical Rheumatology, pp. 1-7. https://doi.org/10.1007/s10067-016-3453-0
Ceribelli, Angela ; Isailovic, Natasa ; de Santis, Maria ; Generali, Elena ; Fredi, Micaela ; Cavazzana, Ilaria ; Franceschini, Franco ; Cantarini, Luca ; Satoh, Minoru ; Selmi, Carlo. / Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis. In: Clinical Rheumatology. 2016 ; pp. 1-7.
@article{afc37c307a4147b6abf812807807c262,
title = "Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis",
abstract = "This study aims to characterize myositis-specific antibodies in a well-defined cohort of patients with idiopathic inflammatory myopathy and to determine their association with cancer. Sera from 40 patients with polymyositis, dermatomyositis, and controls were tested by protein and RNA immunoprecipitation to detect autoantibodies, and immunoprecipitation-Western blot was used for anti-MJ/NXP-2, anti-MDA5, and anti-TIF1γ/α identification. Medical records were re-evaluated with specific focus on cancer. Anti-MJ/NXP-2 and anti-TIF1γ/α were the most common antibodies in dermatomyositis. In six dermatomyositis cases, we found five solid forms of cancer and one Hodgkin’s lymphoma in long-term remission. Among patients with cancer-associated dermatomyositis, three were positive for anti-TIF1γ/α, two for anti-Mi-2, and one for anti-MJ/NXP-2. The strongest positivity of anti-TIF1γ was seen in two active forms of cancer, and this antibody was either negative or positive at low titers in the absence of cancer or in the 7-year remission Hodgkin’s lymphoma. Four out of twenty (20 {\%}) patients with polymyositis had solid cancer, but no specific association with autoantibodies was identified; further, none of the four cases of antisynthetase syndrome had a history of cancer. No serum myositis-associated autoantibody was observed in control sera, resulting in positive predictive value 75 {\%}, negative predictive value 78.5 {\%}, sensitivity 50 {\%}, specificity 92 {\%}, and area under the ROC curve 0.7083 for the risk of paraneoplastic DM in anti-TIF1γ/α (+) patients. Myositis-specific autoantibodies can be identified thanks to the use of immunoprecipitation, and their association with cancer is particularly clear for anti-TIF1γ/α in dermatomyositis. This association should be evaluated in a prospective study by immunoprecipitation in clinical practice.",
keywords = "Biomarkers, Cancer, Idiopathic inflammatory myositis, Immunoprecipitation",
author = "Angela Ceribelli and Natasa Isailovic and {de Santis}, Maria and Elena Generali and Micaela Fredi and Ilaria Cavazzana and Franco Franceschini and Luca Cantarini and Minoru Satoh and Carlo Selmi",
year = "2016",
month = "10",
day = "20",
doi = "10.1007/s10067-016-3453-0",
language = "English (US)",
pages = "1--7",
journal = "Clinical Rheumatology",
issn = "0770-3198",
publisher = "Springer London",

}

TY - JOUR

T1 - Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis

AU - Ceribelli, Angela

AU - Isailovic, Natasa

AU - de Santis, Maria

AU - Generali, Elena

AU - Fredi, Micaela

AU - Cavazzana, Ilaria

AU - Franceschini, Franco

AU - Cantarini, Luca

AU - Satoh, Minoru

AU - Selmi, Carlo

PY - 2016/10/20

Y1 - 2016/10/20

N2 - This study aims to characterize myositis-specific antibodies in a well-defined cohort of patients with idiopathic inflammatory myopathy and to determine their association with cancer. Sera from 40 patients with polymyositis, dermatomyositis, and controls were tested by protein and RNA immunoprecipitation to detect autoantibodies, and immunoprecipitation-Western blot was used for anti-MJ/NXP-2, anti-MDA5, and anti-TIF1γ/α identification. Medical records were re-evaluated with specific focus on cancer. Anti-MJ/NXP-2 and anti-TIF1γ/α were the most common antibodies in dermatomyositis. In six dermatomyositis cases, we found five solid forms of cancer and one Hodgkin’s lymphoma in long-term remission. Among patients with cancer-associated dermatomyositis, three were positive for anti-TIF1γ/α, two for anti-Mi-2, and one for anti-MJ/NXP-2. The strongest positivity of anti-TIF1γ was seen in two active forms of cancer, and this antibody was either negative or positive at low titers in the absence of cancer or in the 7-year remission Hodgkin’s lymphoma. Four out of twenty (20 %) patients with polymyositis had solid cancer, but no specific association with autoantibodies was identified; further, none of the four cases of antisynthetase syndrome had a history of cancer. No serum myositis-associated autoantibody was observed in control sera, resulting in positive predictive value 75 %, negative predictive value 78.5 %, sensitivity 50 %, specificity 92 %, and area under the ROC curve 0.7083 for the risk of paraneoplastic DM in anti-TIF1γ/α (+) patients. Myositis-specific autoantibodies can be identified thanks to the use of immunoprecipitation, and their association with cancer is particularly clear for anti-TIF1γ/α in dermatomyositis. This association should be evaluated in a prospective study by immunoprecipitation in clinical practice.

AB - This study aims to characterize myositis-specific antibodies in a well-defined cohort of patients with idiopathic inflammatory myopathy and to determine their association with cancer. Sera from 40 patients with polymyositis, dermatomyositis, and controls were tested by protein and RNA immunoprecipitation to detect autoantibodies, and immunoprecipitation-Western blot was used for anti-MJ/NXP-2, anti-MDA5, and anti-TIF1γ/α identification. Medical records were re-evaluated with specific focus on cancer. Anti-MJ/NXP-2 and anti-TIF1γ/α were the most common antibodies in dermatomyositis. In six dermatomyositis cases, we found five solid forms of cancer and one Hodgkin’s lymphoma in long-term remission. Among patients with cancer-associated dermatomyositis, three were positive for anti-TIF1γ/α, two for anti-Mi-2, and one for anti-MJ/NXP-2. The strongest positivity of anti-TIF1γ was seen in two active forms of cancer, and this antibody was either negative or positive at low titers in the absence of cancer or in the 7-year remission Hodgkin’s lymphoma. Four out of twenty (20 %) patients with polymyositis had solid cancer, but no specific association with autoantibodies was identified; further, none of the four cases of antisynthetase syndrome had a history of cancer. No serum myositis-associated autoantibody was observed in control sera, resulting in positive predictive value 75 %, negative predictive value 78.5 %, sensitivity 50 %, specificity 92 %, and area under the ROC curve 0.7083 for the risk of paraneoplastic DM in anti-TIF1γ/α (+) patients. Myositis-specific autoantibodies can be identified thanks to the use of immunoprecipitation, and their association with cancer is particularly clear for anti-TIF1γ/α in dermatomyositis. This association should be evaluated in a prospective study by immunoprecipitation in clinical practice.

KW - Biomarkers

KW - Cancer

KW - Idiopathic inflammatory myositis

KW - Immunoprecipitation

UR - http://www.scopus.com/inward/record.url?scp=84991794162&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84991794162&partnerID=8YFLogxK

U2 - 10.1007/s10067-016-3453-0

DO - 10.1007/s10067-016-3453-0

M3 - Article

AN - SCOPUS:84991794162

SP - 1

EP - 7

JO - Clinical Rheumatology

JF - Clinical Rheumatology

SN - 0770-3198

ER -